Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-08-12 00:00:00 ET · period of report 2025-08-11 · accession 0001415889-25-021521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-12 | 2025-08-11 | MIRM | Peetz Christopher | CEO, Dir | S - Sale+OE | $62.00 | -40.0K | 138.6K | -22% | -$2.48M |
| D | 2025-08-12 | 2025-08-11 | MIRM | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +40.0K | 178.6K | +29% | +$117.6K |
| D | 2025-08-12 | 2025-08-11 | MIRM | Peetz Christopher | CEO, Dir | M - OptEx | $0.00 | -40.0K | 158.5K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-11 | S | D | 40,000 | $62.00 | 138,641 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-11 | M | A | 40,000 | $2.94 | 178,641 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-08-11 | M | D | 40,000 | $0.00 | 158,487 | D | $2.94 · — to 2029-03-11 | 40,000 Common Stock | (F2) The stock option is fully vested. |